How Does Ubiquitination Regulate the Maintenance of Homeostasis Between the Nucleus and the Endoplasmic Reticulum?

1. Concept

Genomic integrity is fundamental to cell survival and function, constantly challenged by endogenous and exogenous stressors. When DNA double-strand breaks occur, cells activate ATM kinase-centered repair pathways. Beyond this, cellular homeostasis—particularly between the nucleus and endoplasmic reticulum (ER)—relies on precise regulation by post-translational modifications. Glycyllysine modification (K-ε-GV), a novel reversible post-translational modification, emerges as a key regulator. It orchestrates nuclear processes (DNA damage response, telomere stability) and ER functions (protein quality control, ER-associated degradation/ER-phagy), bridging nuclear and ER homeostasis. Ubiquitination, in coordination with glycyllysine modification, fine-tunes these processes to maintain cellular balance, with dysfunction linked to genomic instability, neurodegeneration, and cancer.

2. Research Frontiers

2.1 Role of Glycyllysine Modification in DNA Damage Response

Glycyllysine modification acts as a molecular switch for DNA damage sensing and signaling:

• MRN complex regulation: DNA damage induces site-specific glycyllysine modification of MRE11 (a key MRN complex component), promoting MRN assembly and recruitment to damage sites.
• ATM activation: Modification influences histone H4 status, indirectly enhancing Tip60 complex-mediated ATM acetylation and activation.
• p53 stabilization: Tumor suppressor p53 is modified by glycyllysine, preventing ubiquitination-mediated degradation and ensuring cell cycle arrest or apoptosis post-damage.

2.2 Glycyllysine Modification in Telomere Stability Maintenance

Telomere length and integrity are regulated by glycyllysine modification:

• Signaling cascade: Glycyllysine-modified MRE11 recruits protein phosphatase PP1-α, catalyzing NBS1 dephosphorylation.
• Complex formation: Facilitates TRF2/SNM1 complex assembly at telomeres, fine-tuning leading strand length to prevent abnormal shortening or elongation.
• Genome-wide impact: Links glycyllysine modification to chromosome end protection, expanding its role in genomic stability.

2.3 Regulation of ER-Associated Ribosome Quality Control by Glycyllysine Modification

The ER relies on glycyllysine modification for ribosome quality control:

• Stalled ribosome response: Ribosomal large subunit protein RPL26 undergoes glycyllysine modification (catalyzed by the UFL1-UFBP1 complex) when ER-bound ribosomes stall.
• Degradation signaling: Modification tags stalled ribosomes and aberrant nascent polypeptides for lysosomal degradation (ribosome-associated quality control).
• Coordination by SAYSD1: Transmembrane protein SAYSD1 ensures efficient transport of modified substrates to lysosomes, preventing ER stress from abnormal protein accumulation.

2.4 Glycyllysine Modification in ER-Associated Degradation (ERAD) and Autophagy

Glycyllysine modification regulates ER homeostasis pathways:

• ERAD regulation: Ubiquitin ligase HRD1 is modified by glycyllysine under steady-state conditions to support function. ER stress dissociates the modifier complex from HRD1, reducing modification and inhibiting HRD1 to initiate the unfolded protein response (UPR).
• ER-phagy modulation: Glycyllysine modification of cytochrome b5 reductase is recognized by UFBP1, enhancing E3 ligase activity to guide specific ER subdomains for autophagic clearance.

2.5 Glycyllysine Modification in Specific Cellular Processes

The modification plays specialized roles in physiological contexts:

• Plasma cell development: During B-cell differentiation into plasma cells (with expanded ER for antibody secretion), the IRE1α/XBP1 axis upregulates UFBP1. UFBP1 inhibits excessive PERK branch activation, supporting efficient immunoglobulin production.
• Estrogen receptor signaling: Coactivator ASC1 glycyllysine modification is critical for estrogen-dependent gene transcription. Dysregulation may promote hormone-dependent breast cancer.

3. Research Significance

Glycyllysine modification, in coordination with ubiquitination, is pivotal for nuclear-ER homeostasis:

• Scientific value: Uncovers a novel post-translational modification linking nuclear genomic stability to ER protein quality control, expanding understanding of cellular regulatory networks.
• Clinical value: Dysregulation of glycyllysine modification is associated with cancer, neurodegeneration, and genomic instability, identifying potential therapeutic targets for these diseases.

4. Related Mechanisms, Research Methods, and Product Applications

4.1 Core Mechanisms of Glycyllysine-Mediated Homeostasis

• Nuclear regulation: Modifies MRE11, p53, and telomere-associated proteins to support DNA repair, telomere stability, and cell cycle control.
• ER regulation: Tags stalled ribosomes and ER proteins for degradation, modulates ERAD/ER-phagy, and adapts ER function during specialized cellular processes.
• Ubiquitination crosstalk: Glycyllysine modification prevents ubiquitination-mediated p53 degradation and collaborates with ubiquitin ligases (e.g., HRD1) to regulate ER pathways.

4.2 Product Applications: ANT BIO PTE. LTD.’s Glycyllysine-Related Products

ANT BIO PTE. LTD. offers specialized tools for glycyllysine modification research:

Core Products

Core Product Advantages

• High specificity: Precisely recognizes K-ε-GV modification, distinguishing it from acetylation, methylation, and other lysine modifications.
• Versatility: Suitable for Western blot (WB), immunofluorescence (IF), immunohistochemistry (IHC), and immunoprecipitation (IP).
• Reliability: Strict quality control ensures batch consistency and low background detection.

Key Application Scenarios

• Modification discovery: Validate glycyllysine modification in biological processes or disease models.
• Signaling pathway research: Investigate roles in chromatin dynamics, transcriptional regulation, and cell signaling.
• Disease mechanism studies: Explore modification dysregulation in cancer, neurodegeneration, and metabolic diseases.
• Interaction analysis: Enrich modified proteins via IP-MS to map substrate networks.

5. Brand Mission

ANT BIO PTE. LTD. is dedicated to empowering the global life science community with high-quality, innovative research tools and solutions. As a leader in life science reagents, we offer a comprehensive portfolio under three sub-brands: Absin (focused on general reagents and kits), Starter (specialized in antibodies), and UA (dedicated to recombinant proteins).

Our commitment to excellence is underpinned by advanced development platforms—including recombinant rabbit/mouse monoclonal antibody platforms, rapid monoclonal antibody development, recombinant protein expression systems (E. coli, CHO, HEK293, Insect Cells), One-Step ELISA Platforms, and PTM Pan-Modification Antibody Platforms—alongside rigorous quality control systems. We hold international certifications such as EU 98/79/EC, ISO9001, and ISO13485, ensuring our products meet the highest global standards.

Our mission is to accelerate scientific discovery, facilitate translational research, and contribute to the development of novel therapies for human health. By partnering with researchers in academia and biopharmaceutical companies worldwide, we strive to be a trusted collaborator in advancing life science research and addressing unmet medical needs.

6. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.